Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)
Clinical trial NCT05404139 · RECRUITING
Trial details
- NCT number
- NCT05404139
- Sponsor
- University Health Network, Toronto
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-24
- Primary completion
- 2031-02-01
- Enrollment
- 352
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.